Literature DB >> 17936697

Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.

Azadeh Khalili-Shirazi1, Maria Kaisar, Gary Mallinson, Samantha Jones, Daljit Bhelt, Carol Fraser, Anthony R Clarke, Simon H Hawke, Graham S Jackson, John Collinge.   

Abstract

Prion diseases are associated with accumulation of strain-dependent biochemically distinct, disease-related isoforms (PrP(Sc)) of host-encoded prion protein (PrP(C)). PrP(Sc) is characterised by increased beta-sheet content, detergent insolubility and protease resistance. Recombinant alpha-PrP adopts a PrP(C)-like conformation, while beta-PrP conformationally resembles PrP(Sc), to these we raised 81 monoclonal antibodies in Prnp(0/0) mice. The N-terminal residues 91-110 are highly immunogenic in beta-PrP-immunised mice and of (17/41) anti-beta-PrP antibodies that could be epitope-mapped, approximately 70%, recognised this segment. In contrast, only 3/40 anti-alpha-PrP antibodies could be mapped and none interacted with this region, instead recognising residues 131-150, 141-160 and 171-190. Native PrP(C) was recognised by both antibody groups, but only anti-beta-PrP antibodies directed to 91-110 residues recognised native PrP(Sc) with high affinity, where in addition, species heterogeneity was also evident. Within the six anti-beta-PrP antibodies studied, they all recognised PK-treated native human and mouse PrP(Sc), four failed to recognise PK-treated native bovine PrP(Sc), one of which also did not recognise native PK-treated ovine PrP(Sc), showing the epitope becomes exposed on unfolding and disaggregation. These results demonstrate strain-dependent variations in chain conformation and packing within the 91-110 region of PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936697     DOI: 10.1016/j.bbapap.2007.08.028

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Authors:  Toshiya Kubota; Yuta Hamazoe; Shuhei Hashiguchi; Daisuke Ishibashi; Kazuyuki Akasaka; Noriyuki Nishida; Shigeru Katamine; Suehiro Sakaguchi; Ryota Kuroki; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

2.  Characterization of conformation-dependent prion protein epitopes.

Authors:  Hae-Eun Kang; Chu Chun Weng; Eri Saijo; Vicki Saylor; Jifeng Bian; Sehun Kim; Laylaa Ramos; Rachel Angers; Katie Langenfeld; Vadim Khaychuk; Carla Calvi; Jason Bartz; Nora Hunter; Glenn C Telling
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

3.  Conformation-dependent epitopes recognized by prion protein antibodies probed using mutational scanning and deep sequencing.

Authors:  Kyle M Doolan; David W Colby
Journal:  J Mol Biol       Date:  2014-11-07       Impact factor: 5.469

4.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.

Authors:  Darragh B Freir; Andrew J Nicoll; Igor Klyubin; Silvia Panico; Jessica M Mc Donald; Emmanuel Risse; Emmanuel A Asante; Mark A Farrow; Richard B Sessions; Helen R Saibil; Anthony R Clarke; Michael J Rowan; Dominic M Walsh; John Collinge
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

5.  Crystal structure of human prion protein bound to a therapeutic antibody.

Authors:  S V Antonyuk; C R Trevitt; R W Strange; G S Jackson; D Sangar; M Batchelor; S Cooper; C Fraser; S Jones; T Georgiou; A Khalili-Shirazi; A R Clarke; S S Hasnain; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

6.  Conformational properties of beta-PrP.

Authors:  Laszlo L P Hosszu; Clare R Trevitt; Samantha Jones; Mark Batchelor; David J Scott; Graham S Jackson; John Collinge; Jonathan P Waltho; Anthony R Clarke
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

7.  Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay.

Authors:  Emmanuel Risse; Andrew J Nicoll; William A Taylor; Daniel Wright; Mayank Badoni; Xiaofan Yang; Mark A Farrow; John Collinge
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

8.  The N-terminus of the prion protein is a toxic effector regulated by the C-terminus.

Authors:  Bei Wu; Alex J McDonald; Kathleen Markham; Celeste B Rich; Kyle P McHugh; Jörg Tatzelt; David W Colby; Glenn L Millhauser; David A Harris
Journal:  Elife       Date:  2017-05-20       Impact factor: 8.140

9.  The N-terminal sequence of prion protein consists an epitope specific to the abnormal isoform of prion protein (PrP(Sc)).

Authors:  Kentaro Masujin; Yuko Kaku-Ushiki; Ritsuko Miwa; Hiroyuki Okada; Yoshihisa Shimizu; Kazuo Kasai; Yuichi Matsuura; Takashi Yokoyama
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.

Authors:  Neng-Wei Hu; Andrew J Nicoll; Dainan Zhang; Alexandra J Mably; Tiernan O'Malley; Silvia A Purro; Cassandra Terry; John Collinge; Dominic M Walsh; Michael J Rowan
Journal:  Nat Commun       Date:  2014-03-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.